Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876

Cited by (299)

Items 201–299 of 299

1. Structural aspects of the glucose and monocarboxylate transporters involved in the Warburg effect
   Xin Jian Jiang, Nieng Yan, Dong Deng, Chuangye Yan · 2022 · IUBMB Life
2. Targeted blocking of EGFR and GLUT1 by compound H reveals a new strategy for treatment of triple-negative breast cancer and nasopharyngeal carcinoma
   Chunmiao Wang, Zhaoquan Li, Honglan Zhai, Xiaoyan Shen, Fengming Li, Qiuping Zhang, Danrong Li, Huaxin Hou · 2024 · European Journal of Pharmaceutical Sciences
3. Targeting cancer metabolism through synthetic lethality-based combinatorial treatment strategies
   Richa Bajpai, Mala Shanmugam · 2018 · Current Opinion in Oncology
4. Starving the Devourer: Cutting Cancer Off from Its Favorite Foods
   William P. Katt, Michael J. Lukey, Richard A. Cerione · 2019 · Cell chemical biology
5. Direct targeting of GLUT1 in cancer: A decade of inhibitor discovery and medicinal chemistry insights
   Zihan Meng, Erkang Tian, Weipeng Hu, Changyu Ren, J W Li · 2026 · Medicinal Chemistry Research
6. Molecular characterization of glutor-GLUT interaction and prediction of glutor’s drug-likeness: implications for its utility as an antineoplastic agent
   Mithlesh Kumar Temre, Bharti Devi, Vinay Kumar Singh, Yugal Goel, Saveg Yadav, Shrish Kumar Pandey, Rajnish Kumar, Ajay Kumar, Sukh Mahendra Singh · 2022 · Journal of Biomolecular Structure and Dynamics
7. Construction of a disulfidptosis-related glycolysis gene risk model to predict the prognosis and immune infiltration analysis of gastric adenocarcinoma
   Zhaohui Liao, Zhengyuan Xie · 2024 · Clinical & Translational Oncology
8. Role of disulfide death in cancer (Review)
   Xue Li, Danxia Zhu · 2024 · Oncology Letters
9. Advances in the design and application of glycolysis-related nanodelivery systems for anti-tumor
   Yanghui Zhou, Meijing Liu, Na Lü, Xiangping Deng, Xin Chen, Lijing Tang, Zhizhong Xie, Xiaoyong Lei, Xiaoyan Yang, Saidong Zhou et al. · 2025 · Colloids and Surfaces B Biointerfaces
10. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays
    Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, Wukun Liu, Hanjing Peng, Yuefan Wang, Alka Rao, Ruo‐jing Li, Xue Ying, Preethi C. Korangath et al. · 2019 · Angewandte Chemie
11. Tumor Metabolism: Focused on Tumor Glycolysis, Progress, and Prospects in Cancer Therapy
    Atul Kumar, Mamta Singh, Dolly Sharma, Vinit Kumar, Reshma Rani · 2021 · Burger's Medicinal Chemistry and Drug Discovery
12. Prodigiosin regulates cancer metabolism through interaction with GLUT1
    Hyun-A Yang, Tae-Hee Han, Keeok Haam, Kyung‐Soo Lee, Jin Su Kim, Tae-Su Han, Moo‐Seung Lee, Hyun Seung Ban · 2024 · Natural Product Research
13. Recent Advances in Development of Bioactive Fluorinated Pyrazole Derivatives: A Review
    Priyesh H. Amin, Rajesh H. Vekariya, Sureshkumar K. Dhakhda · 2024 · ChemistrySelect
14. 4-Furanylvinylquinoline derivative as a new scaffold for the design of oxidative stress initiator and glucose transporter inhibitor drugs
    Michał Kuczak, Wioleta Cieślik, Robert Musioł, Anna Mrozek‐Wilczkiewicz · 2024 · Scientific Reports
15. Glut-1 inhibition in breast cancer cells
    Ajeesh Babu Littleflower, Sulfath Thottungal Parambil, Gisha Rose Antony, A. S., Lakshmi Subhadradevi · 2025 · Vitamins and hormones
16. Sex- and depot-specific differences in cellular insulin responsiveness during adipose expansion
    Mathis Neuhaus, Karin G. Stenkula · 2025 · Life Sciences
17. The pro‐proliferative effect of insulin in human breast epithelial DMBA ‐transformed and non‐transformed cell lines is PI3K ‐, mTOR ‐ and GLUT1 ‐dependent
    Cláudia Silva, Nelson Andrade, João Tiago Guimarães, Emília Cardoso, Catarina Meireles, Vanessa Pinto, Joana S. Paiva, Fátima Martel · 2022 · Cell Biochemistry and Function
18. Target Separation and Potential Anticancer Activity of Withanolide-Based Glucose Transporter Protein 1 Inhibitors from Physalis angulata var. villosa
    Jinghan Zhang, Xiao Xu, Yu Zhao, Chunling Ren, Mengzhen Gu, Haili Zhang, Peiye Wu, Yun Wang, Lingyi Kong, Chao Han · 2023 · Journal of Natural Products
19. α-tocopherol prevents oxidative stress-induced proliferative dysfunction in first-trimester human placental (HTR-8/SVneo) cells
    Lígia Pinto-Ribeiro, Cláudia Silva, Nelson Andrade, Fátima Martel · 2022 · Reproductive Biology
20. RAS: Circuitry and therapeutic targeting
    Gagandeep Singh, Neelam Thakur, Umesh Kumar · 2022 · Cellular Signalling
21. Mechanistic insights into disulfidptosis in cancer and therapeutic opportunities
    Negar Hemmati, Sajjad Mozaffari, Mahdieh Anoush, Bahman Abedi Kiasari · 2026 · Discover Oncology
22. Targeting the Glucose–Insulin Link in Head and Neck Squamous Cell Carcinoma Induces Cytotoxic Oxidative Stress and Inhibits Cancer Growth
    Simbarashe Mazambani, Seong-Ho Park, Joshua H. Choe, An H. Nguyen, Bok‐Soon Lee, Ji Yun Jeong, Shin Yup Lee, Chul‐Ho Kim, Yea–In Park, Joselyn Padilla et al. · 2025 · Cancer Research Communications
23. A mitochondria-targeting glutathione fluorescent probe reveals distinct mitochondria-endoplasmic reticulum contact between disulfidptosis and ferroptosis
    Si-Ling Chen, Liu Yang, Yu‐Zhong Xie, Ming‐Hua Zheng, Jing-Yi Jin · 2025 · Bioorganic Chemistry
24. Efficient one-pot synthesis of 3-(polyfluoroalkyl)pyrazol-4-amines
    V. I. Filyakova, N. S. Boltacheva, Pavel Alexandrovich Slepukhin, Валерий Николаевич Чарушин · 2023 · Chemistry of Heterocyclic Compounds
25. Breast cancer therapy: from the perspective of glucose metabolism and glycosylation
    Jiaqi Zhao, Haiting Sun, Che Wang, Dejing Shang · 2024 · Molecular Biology Reports
26. Drug Screening for Glycolysis Pathway in Living Cancer Cells Using 19F NMR
    Biao Liu, Tao Huang, Xiong Xiao, Xin Chai, Yating Lei, Qiuyun Sun, Qin Hu, Qinjun Zhu, Danyun Zeng, Caixiang Liu et al. · 2025 · Analytical Chemistry
27. Small Molecule Modulation of GLUT1-Mediated Glucose Transport
    Ogooluwa Ojelabi · 2017 · The Journal of the American Medical Association (JAMA) Network (American Medical Association)
28. Influence of Linker Molecules on the Biodistribution Characteristics of 99mTc-labeled Mannose Derivatives with an Isocyanide-Coordinated Group
    Guangxing Yin, Yuhao Jiang, Junhong Feng, Qing Zhao Ruan, Qianna Wang, Peiwen Han, Junbo Zhang · 2025 · ACS Pharmacology & Translational Science
29. Oxidative stress and cancer metabolism: From pathogenesis to therapeutic opportunities
    Tejas Girish Agnihotri, Shyam Sudhakar Gomte, Biswajit Rout, Vasu Peddinti, Sandeep Kr Maharana, Devaraj Yallappa, Aakanchha Jain · 2025 · Elsevier eBooks
30. Oxidative stress-driven m5C methylation by NSUN5 confers cisplatin resistance in lung adenocarcinoma through promoting glycolysis
    Xin Wang, Jinfeng Ning, Mengru Cao, Wei Liu, Siyi Sun, Man Dou, Li Cai, Ying Xing · 2026 · Redox Biology
31. Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer
    Scott Best, Daniel S. Hippe, Eli Grunblatt, Jackson P. Fatherree, Pritha Chanana, Feinan Wu, Richard G. Ivey, Jacob J. Kennedy, David Sokolov, Ali Ibrahim et al. · 2026 · Nature Communications
32. Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growth
    Yu Xia, Ming‐Kang Zhang, Jing‐Jie Ye, Mei‐Ting Niu, Ziyang Wang, Xinyi Dai, Zhiling He, Jun Feng · 2024 · Biomaterials Science
33. The cytotoxic effect of crocin and chrysin on the AsPC-1 pancreatic cancer cell line is related to inhibition of nutrient uptake
    Sara Pinto, Nelson Andrade, Francisca Carmo, Cláudia Silva, Fátima Martel · 2025 · PharmaNutrition
34. Progress of research on glucose transporter proteins in hepatocellular carcinoma
    Zheng Ruan, Yanjun Wang, Lei Shi, Xiaojun Yang · 2025 · World Journal of Hepatology
35. Identification of Rapaglutin E as an Isoform-Specific Inhibitor of Glucose Transporter 1
    Marnie Kotlyar, Zufeng Guo, Alka Rao, Hanjing Peng, Jingxin Wang, Zhongnan Ma, Cordelia Schiene‐Fischer, Günter Fischer, Jun O. Liu · 2025 · ACS Chemical Biology
36. Reduction of Trifluoromethyl-containing 4-Nitroso- and 4-Arylazopyrazoles as a Method for 4-Amino-3-trifluoromethylpyrazoles Synthesis
    Natalia А. Elkina, Anastasia N. Perminova, Natalia A. Agafonova, Evgeny V. Shchegolkov, Yanina V. Burgart, М. Г. Первова, Mariya Andreyevna Samorukova, В. И. Салоутин · 2022 · Russian Journal of General Chemistry
37. Derivation of functional retinal endothelial cells from human pluripotent stem cells for therapeutics and modeling
    Ying-Yu Lin, Parker J. Esswein, Lucas Ramirez, Emily C. Warren, Sharon Gerecht · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
38. Glucose protects cultured retinal cells from oxidative injury via the pentose phosphate pathway
    John P. M. Wood, Glyn Chidlow, Robert James Casson · 2025 · Free Radical Biology and Medicine
39. CELF1 promotes aerobic glycolysis and an aggressive phenotype in ER-positive breast cancer via GLUT1 regulation
    Jinyu Li, Ning Wang, Jianlei Bi, Mei-Hua Guo, Bingbing Xu, Ge-Na Huang · 2025 · Frontiers in Genetics
40. Rewiring Tumor Metabolism for Lethality: Nanomedicine-Mediated Induction of Metabolic Cell Death
    Hongdu Liu, Shuang-Yan He, Yun Huang, Jia Liu, Ya-Lan Chen, Hua Wei, Cui-Yun Yu · 2026 · Precision Medicine and Engineering
41. A glucose metabolism-targeted nanoplatform amplifies disulfidptosis-associated immunogenic cell death in triple-negative breast cancer
    Jialin Xu, Yanting Sun, Bin Huang, Yifan Zhang, Hongyu Shen, Zhengxing Zhou, Min Tian, Tianyu Zeng, Shuai Wu, Yongmei Yin · 2026 · Redox Biology
42. Pyridazines and Their Benzo Derivatives
    Gary M. Chinigo, Yiqing Feng, Susan Hoy, Ricardo Lira, Matthew Perry · 2021 · Elsevier eBooks
43. Discovery of lead compounds from pseudo-natural macrocycles enabled by modular biomimetic strategy
    Bichao Song, Ke‐Qiang Hou, Weibo Yang · 2024 · Elsevier eBooks
44. Transcellular transport of 18 F-deoxyglucose via facilitative glucose channels in experimental peritoneal dialysis
    Giedre Martus, Premkumar Siddhuraj, Jonas Sten Erjefalt, András Kádár, Martin Lindström, Karin Bergling, Carl Mikael Öberg · 2024 · Peritoneal Dialysis International
45. The molecular mechanism underlying the human glucose facilitators inhibition
    Cantao Quan, Xin Jian Jiang · 2025 · Vitamins and hormones
46. Repurposing mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 for cancer therapy
    T. Schumacher, Ananth V. Iyer, Jon N. Rumbley, Conor T. Ronayne, Venkatram R. Mereddy · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
47. Multiplexed High-throughput Screenings for Immune Modulators of Cytotoxic T Lymphocyte
    Ziyan Zhao · 2018 · OpenCommons at University of Connecticut (University of Connecticut)
48. Glucose transporter 1 and prognosis in cancer
    Hiroshi Sawayama, Hideo Baba · 2019 · Elsevier eBooks
49. Towards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)
    Calin, George, Paul M Hofman, Sendurai A. Mani · 2019 · MDPI eBooks
50. Faculty Opinions recommendation of Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion.
    Johan de Rooij, Antoine Khalil · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
51. Faculty Opinions recommendation of Donated chemical probes for open science.
    David C. Swinney · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
52. A Surge of Extracellular Succinate Ensures Glucose Supply During Systemic High Energy Demand
    Yan‐Ling Wu, Ulrika K. Andersson-Hall, Haiqiang Dou, Man Mohan Shrestha, Ali M. Komai, Johan Tolö, Stefan Pettersson, Anders Pedersen, Belén Chanclón, Marco Bauzá-Thorbrügge et al. · 2022 · SSRN Electronic Journal
53. The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through reprogramming energy metabolism
    Jingrou Chen, Shu‐Juan Xie, Dongbo Qiu, Maosheng Xie, Mengye Wu, Xiaoping Li, Xiaoran Zhang, Qili Wu, Yi Xiong, Chang You Wu et al. · 2023 · Research Square
54. Data from Diaminobutoxy-substituted Isoflavonoid (DBI-1) Enhances the Therapeutic Efficacy of GLUT1 Inhibitor BAY-876 by Modulating Metabolic Pathways in Colon Cancer Cells
    Lichao Guo, Wen Zhang, Yanqi Xie, Xi Chen, Emma E. Olmstead, Mengqiang Lian, Baochen Zhang, Yekaterina Y. Zaytseva, Bernard Mark Evers, H. Peter Spielmann et al. · 2023
55. Inhibition of Heme Biosynthesis Triggers Cuproptosis in Acute Myeloid Leukaemia
    Alexander Charles Lewis, Emily Gruber, Rheana L. Franich, Jessica M. Armstrong, Madison J. Kelly, Carlos Opazo, Celeste Mawal, Alexandra M. Birrell, Joan So, Keziah E. Ting et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
56. Saccades orchestrate intraocular glucose to shape visual responses in birds
    Xi Xu, Tong Xiao, Yibing Chen, Lijuan Song, Chen Wu, Qian Wang, Tao Zhang, Yan Qin Yang · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
57. OAT1/3 regulate the absorption of CP-25 in the rat synovium
    Jinzhang Gao, Wei Sun, Lei Ni, Qingqing Sun, Jiangrui Cheng, Ning Xiao, Feng Xiao, Wei Wei, Chun Wang · 2025 · Toxicology and Applied Pharmacology
58. ALDH2 Suppresses Glycolysis in Hepatocellular Carcinoma via TRIM21-Mediated GLUT1 Degradation
    Huiyong Yin, Shanshan Zhong, Lili Zhang, Yongqiang Wang, Ningning Liang, Xin Chen, Xuan Yuan, Rui Li, Chunzhao Yin, Chenxi Du et al. · 2025 · Research Square
59. Cancer Nanotheranostics: Emerging Strategies for Diagnosis and Therapeutics in Cancer Metabolism
    Singh Shreya, Debadatta Mohapatra, Alakh N. Sahu · 2025 · Springer eBooks
60. Synthesis and evaluation of novel N,N -dialkylcinnamic acid-based mitochondrial pyruvate carrier inhibitors: Biosynthetic and energetic lethality of targeting metabolic plasticity in cancer
    Sravan K. Jonnalagadda, Conor T. Ronayne, Shirisha Jonnalagadda, Zachary S. Gardner, Venkatram R. Mereddy · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
61. In vitro exposure to the SARS-CoV-2 Spike protein subunit S1 leads to changes in several functional characteristics of human trophoblast cells
    Francisca Carmo, Ilda Rodrigues, Carla Maria Almeida Ramalho, Fátima Martel · 2026 · Placenta
62. Saccades orchestrate intraocular glucose dynamics to shape visual responses in birds
    Xi Xu, Tong Xiao, Yibing Chen, Lijuan Song, Chen Wu, Qian Wang, Tao Zhang, Yan Yang · 2026 · Nature Communications
63. Régulation métabolique de l'infection des cellules T CD4 par VIH-1 : vers de nouvelles cibles thérapeutiques
    Zoï Vahlas · 2020
64. Stress-responsive membrane proteins as execution nodes of tumor cell adaptation to microenvironmental stress
    Xin He, Taoying Huang, ZHEN WANG, Fang Bu, Xu Cao, Meng Xu, Chengsheng Wu · 2026 · Oncogene
65. Étude du rôle du métabolisme intracellulaire des cellules dendritiques dans le développement du psoriasis
    Fairouz N. Zair · 2024 · theses.fr (ABES)
66. Reprogrammation métabolique et résistance aux traitements dans la Leucémie Lymphoïde Chronique : Rôle des exosomes du microenvironnement tumoral
    Kenza Dubois · 2025
67. Modeling VEGF and GLUT1 Expression as Coadapted Foraging Strategies in Cancer
    Ranjini Bhattacharya, Robert A. Gatenby, Joel S. Brown · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
68. In Vitro Evaluation of GLP-1R-Associated Activity of a Sustainable Standardized Phospholipid-Formulated Bergamot Extract
    Amjad Khan, Rosa M. Mella, Patricia Villacé, Meritxell Roura‐Ferrer, Jorge Gamiz, Alessandro Poli, Loredana Redaelli, Giovanna Maresca, Giovanna Petrangolini · 2026 · Biomedicines
69. Glycolysis-driven cancer-associated fibroblasts shape T-Cell exclusion via the CXCL16–CXCR6 Axis: a metabolic-chemokine mechanism in tumor immunity
    Yunya Liu, Chutong Xiong, Guichen Huang, Menghao Xu, Jinxiao Li, Minfeng Zhou, Fengxia Liang, Rui Chen · 2026 · Journal of Translational Medicine
70. Integrating Genome-Scale Metabolic Modeling with Machine Learning Improves Gene Essentiality Prediction in Triple-Negative Breast Cancer
    Bo Kyung Kim, Changdai Gu, Mohamed El-Agamy Farh, Jae Yong Ryu · 2026 · International Journal of Molecular Sciences
71. Dual metabolic intervention nanoplatform co-delivering BAY-876 and L-cystine for Wilms tumor therapy via disulfidptosis-associated cytoskeletal collapse
    Junyi Luo, Tao Mi, Jinkui Wang, Liming Jin, YongLin Mou, Xiaohai Hu, LI Lei, Jiaxin Rao, Peng Guo, Dawei He · 2026 · Journal of Nanobiotechnology
72. Lactate and lactylation in hepatocellular carcinoma: A new frontier in metabolic–epigenetic interactions
    Chen Chen, Yangyang Miao, Songsong Fan, Chengji Tang, Rui Peng, J B Zhang, Jun Cao, Chi Zhang, Dousheng Bai · 2026 · Medical Oncology
73. Discovery of novel GLUT1 inhibitors for lung cancer therapy via structure-based virtual screening and molecular dynamics simulations
    Long Jin, Wanting Yang, Gang Liu, 程春松 · 2026 · Letters in Drug Design & Discovery
74. Glucose and Lactate, Starters or Intermediates of Cancer Metabolic Rewiring
    Cindy Mendes · 2026 · Advances in experimental medicine and biology
75. Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer
    Bhoomendra A. Bhongade, Areeg Anwer Ali, Mohamed El‐Tanani, Shakta Mani Satyam, Sirajunisa Talath, Adil Farooq Wali, Syed Arman Rabbani, Walaa Ibraheem, Karolina Hoffmann, Авагимян Ашот Арманович et al. · 2026 · Current Issues in Molecular Biology
76. Targeting PFKL with S-Benzylisothiourea Imidazolium Salt Derivatives to Suppress Glycolysis and Treat Breast Cancer
    M WANG, Xinge Li, Yan Bai, Wenhan Luo, Yashi Gao, Weilin Xie, Chenhe Su, Junbiao Chang, Bo Zhu · 2026 · Journal of Medicinal Chemistry
77. Targeting GLUTs in Cancer: Mechanisms, Combination Strategies, and Translational Challenges
    Mei-na Shi, Dong-fan Yang, Tong Chu, Da-yuan Zheng, Wenzhe Ma · 2026 · Current Medical Science
78. Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability
    Lourdes Sainero‐Alcolado, Dilraj Lama, Mohammad Alzrigat, Marie Arsenian‐Henriksson · 2026 · BioDrugs
79. Integrating proteomics and metabolomics to reveal MAT2A for metabolic reprogramming in non-small cell lung cancer cells
    Yimin Chen, Yuxi Liu, Zhenyun Zhu, Anqi Ding, Yuying Suo, Cheng Wang, Xiongjun Wang, Hu Zhou, Qiyu Fang, Qian Liu · 2026 · iScience
80. CD36‐Pocket Targeting Induces Metabolic Collapse and Disulfidoptosis for Sonodynamic Immunometabolic Therapy of Liver Cancer
    Liang Zhang, Mengxin He, Yao Lu, Shuai Lu, Jianmin Ding, Hong Ji, Jun Gu Kang, Conghui Han, Jun Yan · 2026 · Small
81. In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity
    Wenlong Jia, Guanxing Yu, Shenqi Han, Zhibo Ma, Jia Liang, Wei Yan, Xinling Zhang, Chenglong Zeng, Lin Xue, Xia Feng et al. · 2026 · Science Immunology
82. Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells
    Abutaleb Asiri, Abeer Al Otaibi, Munazzah Tasleem, Sindiyan Al Shaikh Mubarak, Muwadah Al Said, Yara Abdullah Al Mihmadi, Badr Al Subei, Abdulaziz Asiri, Ali Al Qarni, Ahmed Bakillah · 2026 · Biomedicines
83. Metabolic reprogramming and plasticity in breast Cancer: Mechanisms driving tumor progression, metastasis, and therapeutic resistance
    Jie Yuan, Hua Zhang, Jun Huang, Bei Wang, Minghua Wang, Li Yang · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
84. Chemical Biology‐Based Drug Discovery Workflow Highlights Target Identification as a Key Step in Developing a Novel, Potent, and Selective GLUT1 Inhibitor
    Hiroshi Kamiyama, Yuji Onizawa, Kenji Kubara, Yasunobu Matsumoto, Koji Sagane, Masaharu Gotoda, Takayuki Miyazaki, Yuta Suzuki, Yoshihiko Kotake, Yasutaka Takase et al. · 2026 · ChemBioChem
85. Hijacking Tumor GLUT1 With a Disassemblable Self‐Enhancing Nanoreactor for Metabolic Exhaustion and Anti‐Angiogenesis
    Luming Song, Long Wan, Zhu Liu, Xuanwei Tong, 卞东林, Shuaipeng Feng, Qingqing Xu, Jinghai Zhang, Qinfu Zhao, Siling Wang · 2026 · Advanced Functional Materials
86. Targeting metabolic cell death in cancer to reverse drug resistance
    Tingting Liu, Yixiong Dang, Wen Zhang, Yanting Liu, Yinghua Ji, Ping Lu, Haimin Zou, Wenyong Yang, JINGWEN JIANG · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
87. Research Progress and Challenges in Targeting GLUT1 in Tumors
    Taohua Chen, Bi Peng, Xinya Yuan, Yizhou Liu, Jianing Zhang, Yizhen Su, Guangyuan Hu, Zhen Tao, Guoxian Long · 2026 · International Journal of Molecular Sciences
88. Intratumoral Fusobacterium nucleatum promotes ferroptosis resistance and a disulfide-stress-associated vulnerability under glucose restriction
    Yiqiu Li, Shuheng Dou, Shan Xing, Jiameng Hu, Xiaoyun Pan, Ziqi Yin, Ge Zhang, Songhe Guo · 2026 · Gut Microbes
89. BindingDB Entry 50018672: Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.
    BindingDB · 2024 · UC San Diego
90. BindingDB Entry 50022625: Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876.
    BindingDB · 2025 · UC San Diego
91. BindingDB Entry 50015393: Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179.
    BindingDB · 2023 · UC San Diego
92. BindingDB Entry 50019765: Target Separation and Potential Anticancer Activity of Withanolide-Based Glucose Transporter Protein 1 Inhibitors from
    BindingDB · 2024 · UC San Diego
93. BindingDB Entry 50007948: The Druggability of Solute Carriers.
    BindingDB · 2021 · UC San Diego
94. BindingDB Entry 50022566: GLUT4 expression and glucose transport in human induced pluripotent stem cell-derived cardiomyocytes.
    BindingDB · 2025 · UC San Diego
95. BindingDB Entry 50010394: Discovery and Optimization of Glucose Uptake Inhibitors.
    BindingDB · 2021 · UC San Diego
96. BindingDB Entry 50008525: Discovery of BAY-985, a Highly Selective TBK1/IKKε Inhibitor.
    BindingDB · 2021 · UC San Diego
97. BindingDB Entry 50023044: Recent Progress in the Development of Glucose Transporter (GLUT) Inhibitors.
    BindingDB · 2026 · UC San Diego
98. Disulfidptosis: Current View of Understanding the Novel Pattern of Regulatory Cell Death
    Kaixun Xing, 李晓卿, Ting Li, Shuyan Dong, Hao Zhu, Mingze Yan, Shan Yu, Hongjiang He · 2026 · The International Journal of Biochemistry & Cell Biology
99. GLUT5 Targeted Drug Delivery in Cancer: A Critical Narrative Review of Transporter Specificity and Translational Design
    Saeed Awad M. Alqahtani, Waleed H. Mahallawi, Tareef Sahal Daqqaq, Omar Mansour Al Nozha, Mohammed Adnan Zolaly, Ayman S. Alhasan · 2026 · Pharmaceutics